Ministry Of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna’s Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.214

EQS Newswire / 12/09/2022 / 23:52 EST/EDT Ministry Of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna's Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.214 CAMBRIDGE, MA / ACCESSWIRE / September 12, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA)…

Indonesia’s Bio Farma ready to produce ‘IndoVac’ Covid-19 vaccines

BANDUNG, INDONESIA, Sep 12, 2022 - (ACN Newswire via SEAPRWire.com) - PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, its Covid-19 vaccines brand, including primary series vaccines, booster vaccines and vaccines for children, in development since November 2021.IndoVac Covid-19…

Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines

Bandung, W Java, Indonesia, Sep 9, 2022 - (ACN Newswire via SEAPRWire.com) - PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.IndoVac Covid-19 vaccine in production at PT…

Therapeutic Goods Administration Grants Provisional Approval for Moderna’s COVID-19 Vaccine in Children Aged Six Months to Five Years

Cambridge, MA, Jul 19, 2022 - (ACN Newswire via SEAPRWire.com) - Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a two-dose…

Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea

SEOUL, S.KOREA, Jul 13, 2022 - (ACN Newswire via SEAPRWire.com) - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, congratulates its client SK bioscience on the recent COVID-19 vaccine licence approval.SK bioscience and GSK recently announced the successful authorization:SK bioscience announced…

V-01 as a Sequential Booster Can Produce Good Protection against Omicron —- Latest Phase III Data of COVID-19 Vaccine by Livzon Pharma

HONG KONG, Feb 18, 2022 - (ACN Newswire via SEAPRWire.com) - Global pandemic control is still facing enormous challenges after more than two years since the outbreak of the COVID-19. Following the Delta and Beta variants, Omicron variant emerged at the end of 2021, and its enhanced infectivity has cast…

Therapeutic Goods Administration of Australia Authorizes Moderna’s Covid-19 Vaccine in Children (6-11 Years)

Cambridge, MA, Feb 17, 2022 - (ACN Newswire via SEAPRWire.com) - Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a 50…

Labnovation’s COVID-19 ART Test Kit, Imported by Clearbridge, is One of the Only Two COVID-19 ART Test Kits in the Philippines Approved by the FDA of the Philippines for Self-Testing

Singapore, Jan 26, 2022 - (ACN Newswire via SEAPRWire.com) - Asia's integrated healthcare company, Clearbridge Health Limited ("Clearbridge" or the "Company" and together with its subsidiaries, the "Group"), is pleased to announce that Labnovation Technologies, Inc.'s ("Labnovation") COVID-19 Antigen Rapid ("ART") Test Kit, which is imported by Clearbridge and registered…

Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of the Industry for High Safety and Well Tolerance

HANGZHOU, CHINA, Jan 12, 2022 - (ACN Newswire via SEAPRWire.com) - On January 8, AIM Vaccine held a meeting at Shulan (Hangzhou) Hospital to report on the analysis results of the phase I clinical trial data of its mRNA COVID-19 vaccine (LVRNA009). Safety data on the phase I clinical trial…

Acumen Diagnostics’ PCR capabilities to tackle Omicron COVID-19 variant

SINGAPORE, Dec 3, 2021 - (ACN Newswire via SEAPRWire.com) - Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics" or the "Company"), a 51% owned subsidiary of Q&M Dental Group (Singapore) and 49% owned by Aoxin Q&M Dental, today announced that its proprietary, locally-manufactured polymerase chain reaction ("PCR") test…

A*STAR and Local SME Work with Vaccination Centres to Deploy Automated Systems for Filling Syringes

SINGAPORE, Sep 30, 2021 - (ACN Newswire via SEAPRWire.com) - The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up…

Malaysia Permission Granted for COVID-19 Test Kit from China for Emergency Use; Homegrown Holista Colltech Receives Initial Order for 15,000 Units for Deployment

KUALA LUMPUR, Jun 18, 2021 - (ACN Newswire via SEAPRWire.com) - Amid rising concerns about the threat and economic impact of COVID-19, Holista Colltech Limited has been granted permission for Special access under the Medical Device (Exemption) Order 2016, from the Medical Devices Authority ("MDA") of Malaysia's Ministry of Health…